SATKARTAR
Sat Kartar
Pharmaceuticals
Share price
₹116
Market cap
₹312 Cr
An Ayurveda healthcare company that delivers natural wellness solutions through therapeutic and lifestyle products grounded in traditional Indian medicine. Incorporated in 2012, the company specializes in plant-based formulations designed for health management and wellness across diverse consumer segments. It operates in the growing natural healthcare sector, serving customers who seek traditional remedies and preventive wellness solutions in India's expanding wellness market.
Investors holding Sat Kartar
1.88%
Latest move
A whaleIncreased
Promoter Manprit Singh Chadha increased his stake in Sat Kartar from 20.94% to 23.63% by purchasing 4,24,220 shares for ₹7.08 Cr at ₹167.00 apiece.
Sign in to read more
